Press release
Fabry Disease Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanisms of Action, and Routes of Administration by DelveInsight
Fabry Disease Pipeline
"Fabry Disease Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Fabry Disease Market.
The Fabry Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Request for Sample Report here @ https://www.delveinsight.com/report-store/fabry-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key takeaways from the Fabry Disease Pipeline Report:
• Fabry Disease Companies across the globe are diligently working toward developing novel Fabry Disease treatment therapies with a considerable amount of success over the years.
• Fabry Disease companies working in the treatment market are Protalix Biotherapeutics, Sanofi, 4D Molecular therapeutics, Ozmosis Research Inc, AvroBio, Freeline Therapeutics, Sangamo Therapeutics, Translate Bio, Abeona Therapeutics, AVROBIO, Sangamo Therapeutics, And Many Others, are developing therapies for the Fabry Disease treatment
• Emerging Fabry Disease therapies such as Venglustat, Pegunigalsidase alfa, 4D 310, and others are expected to have a significant impact on the Fabry Disease market in the coming years.
Fabry Disease Overview
Fabry Disease is a rare genetic disorder that prevents the body from making an enzyme called alpha-galactosidase A. This enzyme is responsible for breaking down a type of fat called globotriaosylceramide (Gb3 or GL-3) into building blocks that the body's cells can use. Fabry Disease can have many symptoms because it affects cells throughout the body. The symptoms include: Chronic pain - usually a burning or tingling sensation - in the hands and feet, Clusters of small, dark red spots in various locations on the skin, Opaque corneas, resulting in cloudy-looking eyes and problems with eyesight, Ringing in the ears, and hearing loss. Fabry Disease is caused by a mutation of the GLA gene, which encodes for the alpha-galactosidase A enzyme. The mutation usually makes the enzyme unable to function, although in mild cases, it may function to some degree. The disease is inherited in an X-linked dominant manner, which means that the gene involved is situated on the X chromosome.
Get a Free Sample PDF Report to know more about Fabry Disease Pipeline Therapeutic Assessment- https://www.delveinsight.com/sample-request/fabry-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Fabry Disease Route of Administration
Fabry Disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical.
Fabry Disease Molecule Type
Fabry Disease Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Fabry Disease Pipeline Therapeutics Assessment
• Fabry Disease Assessment by Product Type
• Fabry Disease By Stage and Product Type
• Fabry Disease Assessment by Route of Administration
• Fabry Disease By Stage and Route of Administration
• Fabry Disease Assessment by Molecule Type
• Fabry Disease by Stage and Molecule Type
DelveInsight's Fabry Disease Report covers around 18+ products under different phases of clinical development like-
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Fabry Disease product details are provided in the report. Download the Fabry Disease pipeline report to learn more about the emerging Fabry Disease therapies @ https://www.delveinsight.com/report-store/fabry-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Fabry Disease Pipeline Analysis:
The Fabry Disease pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Fabry Disease with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Fabry Disease Treatment.
• Fabry Disease key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Fabry Disease Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Fabry Disease market.
Download Sample PDF Report to know more about Fabry Disease drugs and therapies- https://www.delveinsight.com/sample-request/fabry-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of Fabry Disease Pipeline Drug Insight
• Coverage: Global
• Key Fabry Disease Companies: Protalix Biotherapeutics, Sanofi, 4D Molecular therapeutics, Ozmosis Research Inc, AvroBio, Freeline Therapeutics, Sangamo Therapeutics, Translate Bio, Abeona Therapeutics, AVROBIO, Sangamo Therapeutics, And Many Others.
• Key Fabry Disease Therapies: Venglustat, Pegunigalsidase alfa, 4D 310, and others.
• Fabry Disease Therapeutic Assessment: Fabry Disease current marketed and Fabry Disease emerging therapies
• Fabry Disease Market Dynamics: Fabry Disease market drivers and Fabry Disease market barriers
Request for Sample PDF Report for Fabry Disease Pipeline Assessment and clinical trials - https://www.delveinsight.com/sample-request/fabry-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Fabry Disease Report Introduction
2. Fabry Disease Executive Summary
3. Fabry Disease Overview
4. Fabry Disease- Analytical Perspective In-depth Commercial Assessment
5. Fabry Disease Pipeline Therapeutics
6. Fabry Disease Late Stage Products (Phase II/III)
7. Fabry Disease Mid Stage Products (Phase II)
8. Fabry Disease Early Stage Products (Phase I)
9. Fabry Disease Preclinical Stage Products
10. Fabry Disease Therapeutics Assessment
11. Fabry Disease Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Fabry Disease Companies
14. Fabry Disease Key Products
15. Fabry Disease Unmet Needs
16 . Fabry Disease Market Drivers and Barriers
17. Fabry Disease Future Perspectives and Conclusion
18. Fabry Disease Analyst Views
19. Appendix
20. About DelveInsight
Trending Reports:
• Asphyxia Market: https://www.delveinsight.com/report-store/asphyxia-market
• Asherman's Syndrome Market: https://www.delveinsight.com/report-store/ashermans-syndrome-market
• Acute Agitation And Aggression Market: https://www.delveinsight.com/report-store/acute-agitation-and-aggression-market
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Chronic pruritus market: https://www.delveinsight.com/report-store/chronic-pruritus-market
• Hiatal hernia market: https://www.delveinsight.com/report-store/hiatal-hernia-market
• Pediatric obesity market: https://www.delveinsight.com/report-store/pediatric-obesity-market
• Acral Lentiginous Melanoma Market: https://www.delveinsight.com/report-store/acral-lentiginous-melanoma-market
• Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
• Aortic Stenosis Market: https://www.delveinsight.com/report-store/aortic-stenosis-market
• Binge Eating Disorder Market: https://www.delveinsight.com/report-store/binge-eating-disorders-market
• Chronic Myelogenous Leukemia Market: https://www.delveinsight.com/report-store/chronic-myelogenous-leukemia-market
• Familial Primary Pulmonary Hypertension Market: https://www.delveinsight.com/report-store/familial-primary-pulmonary-hypertension-market
• Hpv-induced Cancers Market: https://www.delveinsight.com/report-store/hpv-induced-cancers-market
• Meningioma Market: https://www.delveinsight.com/report-store/meningioma-market
• Optic Neuritis Market: https://www.delveinsight.com/report-store/optic-neuritis-market
• Partial Seizure Market: https://www.delveinsight.com/report-store/partial-seizure-market
• Progressive Multifocal Leukoencephalopathy Market: https://www.delveinsight.com/report-store/progressive-multifocal-leukoencephalopathy-market
• Alopecia Market: https://www.delveinsight.com/report-store/alopecia-market
• Cluster Headache Market: https://www.delveinsight.com/report-store/cluster-headache-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Achondroplasia Market: https://www.delveinsight.com/report-store/achondroplasia-market
• Actinic Keratosis Market: https://www.delveinsight.com/report-store/actinic-keratosis-market
• Aesthetic Implants Market: https://www.delveinsight.com/report-store/aesthetic-implants-market
• Alzheimer Disease Market: https://www.delveinsight.com/report-store/alzheimers-disease-ad-market
• Angioedema Market: https://www.delveinsight.com/report-store/angioedema-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Calciphylaxis Market: https://www.delveinsight.com/report-store/calciphylaxis-pipeline-insight
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Chemotherapy Induced Thrombocytopenia Market: https://www.delveinsight.com/report-store/chemotherapy-induced-thrombocytopenia-market-size
• Chronic Lymphocytic Leukemia Cll Market: https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-market
• Concussions Market Size: https://www.delveinsight.com/report-store/concussions-market
• Eczema Market: https://www.delveinsight.com/report-store/eczema-market
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/foot-and-ankle-devices-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Hyperhidrosis Market: https://www.delveinsight.com/report-store/hyperhidrosis-market
• Ventricular Hypertrophy Market: https://www.delveinsight.com/report-store/hypertrophic-cardiomyopathy-pipeline-insight
• Cerebral Aneurysm Market: https://www.delveinsight.com/report-store/intracranial-aneurysms-market-insight
• Lewy Body Dementia Market: https://www.delveinsight.com/report-store/lewy-body-dementia-market
• Multiple Myeloma Market: https://www.delveinsight.com/report-store/multiple-myeloma-market
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/negative-pressure-wound-therapy-systems-market
• Neuroblastoma Market: https://www.delveinsight.com/report-store/neuroblastoma-market
• Neurostimulation Devices Market: https://www.delveinsight.com/report-store/neurostimulation-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Nsclc Market: https://www.delveinsight.com/report-store/non-small-cell-lung-cancer-nsclc-market
• Opioid Induced Constipation Market: https://www.delveinsight.com/report-store/opioid-induced-constipation-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/osteoarthritis-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment
• Pruritus Market: https://www.delveinsight.com/report-store/pruritus-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Chronic Lymphocytic Leukemia Market: https://www.delveinsight.com/report-store/relapsed-chronic-lymphocytic-leukemia-cll-market
• Ventilator Market: https://www.delveinsight.com/report-store/ventilators-market
Contact Us:
Ankit Nigam
Assistant Manager Marketing
info@delveinsight.com
+91-9650213330
https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fabry Disease Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanisms of Action, and Routes of Administration by DelveInsight here
News-ID: 3453330 • Views: …
More Releases from DelveInsight Business Research
Advanced Urothelial Carcinoma Clinical Trials Analysis 2025: Competitive Landsca …
DelveInsight's "Advanced Urothelial Carcinoma Pipeline Insight 2025" delivers an extensive analysis of more than 25 companies and over 30 pipeline therapies in the urothelial carcinoma landscape. The report thoroughly examines pipeline drug profiles across both clinical and preclinical stages. It also provides a detailed assessment by therapy type, development phase, route of administration, and molecular category. In addition, the report highlights inactive or discontinued pipeline products within this therapeutic area.
Explore…
BCL-2 Inhibitors Market Outlook 2034 - Competitive Landscape, Clinical Trials, M …
DelveInsight's BCL-2 Inhibitor Market Insights report delivers a detailed analysis of current therapeutic practices, emerging BCL-2 inhibitors, individual therapy market shares, and the historical and projected market size of BCL-2 inhibitors from 2020 to 2034. The study covers the 7MM markets: the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan.
The BCL-2 inhibitors market is expected to witness significant expansion over the forecast period. This…
Global Medical Device Contract Manufacturing Market to reach USD 79,333.13 milli …
According to DelveInsight's analysis, The increasing prevalence of chronic and infectious diseases is fueling a steady demand for innovative, high-quality medical devices, prompting companies to accelerate their development initiatives. In response, leading medical device firms are boosting R&D investments and partnering with Contract Manufacturing Organizations (CMOs) to lower costs and shorten time-to-market. Alongside rapid technological advancements, this trend is driving a strong global pipeline of medical devices and facilitating regulatory…
Global Intraocular Lens Market Poised to Expand at a CAGR of 6.12% Through 2032, …
According to DelveInsight's analysis, The intraocular lens (IOL) market is experiencing strong growth driven by the increasing prevalence of eye conditions such as cataracts, presbyopia, and astigmatism, which are boosting the need for corrective surgical procedures. This growth is further supported by rising awareness and better accessibility to eye care services, especially in emerging economies, enabling timely diagnosis and treatment. Continuous innovations in lens materials and designs-such as multifocal, toric,…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
